BioStock: FDA clearance opens US market for BiBBInstruments
Medtech company BiBBInstruments recently received 510(k) clearance from the FDA for its lead product, EndoDrill GI. Now, the company expects also a new market approval in Europe – a CE certificate according to MDR – for all products in the EndoDrill product portfolio within 3-6 months. BioStock contacted CEO Fredrik Lindblad for a comment.
Read the interview with Fredrik Lindblad at biostock.se:
FDA clearance opens US market for BiBBInstruments - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/